Effects of newer injectable medication (biological agents) on respiratory function, exercise capacity and sleep quality in patients with bad uncontrolled asthma
Not Applicable
- Conditions
- Health Condition 1: J455- Severe persistent asthma
- Registration Number
- CTRI/2022/10/046458
- Lead Sponsor
- Dr Randeep Guleria
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients with physician-diagnosed severe asthma
2. Age > 18 yrs
3. Planned to receive Benralizumab therapy
4. Patients ready to give consent
Exclusion Criteria
Not giving written informed consent
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method